- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Targacept Inc+ Add to Watchlist
TRGT:US2.5200 USD 0.0600 2.33%
As of 20:10:00 ET on 09/15/2014.
Company Profile for Targacept Inc (TRGT)
Targacept Inc. is a a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors.
Key Executives for Targacept Inc (TRGT)
|Stephen Anthony Hill "Steve"President/CEO||Alan A MussoSenior VP:Finance/CFO/Treasurer|
|Patrick C RockSenior VP/Secy/General Counsel||David A HosfordVP:Clinical Dev & Regulatory|
|Steven M TolerVP:Clinical Pharmaceutical Sciences|